Idiopathic Inflammatory Myopathy
📧 Sign up to get email alerts when something new happens for Idiopathic Inflammatory Myopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) [Phase 2]
Amgen completed a Phase 2 proof-of-concept trial evaluating the efficacy and safety of Daxdilimab in Dermatomyositis and anti-synthetase inf…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. [EARLY_Phase 1]
Phase 1 study evaluating anti-CD19/BCMA universal CAR-T cell therapy RD06-05 in autoimmune diseases; the trial is currently recruiting.
-
CLINICAL_TRIALS other · 2025-09-17Clinical Trial Update: Safety Study of CC312 in Autoimmune Disease Patients [EARLY_Phase 1]
Early-phase safety study of CC312 in multiple autoimmune diseases is currently recruiting, sponsored by CytoCares Inc.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases [Phase 1]
Phase 1 clinical trial of HBI0101 CAR-T therapy for refractory B-cell autoimmune diseases (SLE, systemic sclerosis, idiopathic inflammatory …
-
CLINICAL_TRIALS other · 2025-07-23Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is evaluating the efficacy and safety of subcutaneous Efgartigimod PH20 (efgartigimod alfa) in adults with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: GC012F in Patients With Autoimmune Diseases [EARLY_Phase 1]
This early-phase trial update reports on GC012F being studied for autoimmune diseases (systemic sclerosis and idiopathic inflammatory myopat…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV [EARLY_Phase 1]
This update covers an early-phase Phase 1 trial of RD06-04, a targeted CD19 universal CAR-T cell therapy, for idiopathic inflammatory myopat…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 study evaluating OL-108 in relapsed/refractory autoimmune diseases is currently recruiting, including systemic lupus erythematosus…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank
Clinical trial update noting ongoing recruitment for a biobank–associated study of inflammatory myopathies, including idiopathic inflammator…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: MYOPROSP - a Prospective Cohort Study in Myositis
Clinical trial update for MYOPROSP, a prospective cohort study in myositis, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Renal Manifestations During Idiopathic Inflammatory Myopathies
A recruiting clinical trial at University Hospital, Strasbourg, France is investigating renal manifestations in patients with idiopathic inf…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Clinical Database and Biobank of Patients With Inflammatory Myopathies: the MASC Project (Myositis, DNA, Serum, Cells) (MASC)
The MASC Project is a clinical database and biobank collecting DNA, serum, cells, and clinical data from patients with inflammatory myopathi…
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells [Phase 4]
A Phase 4 clinical trial evaluating mycophenolate mofetil (MMF) in treating idiopathic inflammatory myopathy-associated interstitial lung di…
-
CLINICAL_TRIALS trial_result · 2018-08-06Clinical Trial Update: Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases [Phase 1]
Phase 1 trial update on stem cell transplantation for idiopathic inflammatory myopathy diseases, terminated with results posted in 2018.